Healthsnap on Epicardial Adipose Tissue Study

Not Applicable

Completed

• Conditions: Obesity; Pre Diabetes
• Interventions: Behavioral: HealthSnap; Behavioral: dietary counseling

• Registration Number: NCT03683888
• Lead Sponsor: University of Miami

Brief Summary

The purpose of this research study is to learn about the effectiveness of HealthSnap assessment, to reduce epicardial fat thickness. Excessive epicardial fat is associated with higher risk of developing diabetes and heart diseases. HealthSnap Assessment is a simple, quick and not invasive tool that will provide the patient with a personalized information nutritional and exercise plan.The use of HealthSnap in the clinical practice has not been evaluated, yet.

Detailed Description

This study will evaluate the practicality of adding the HealthSnap algorithm to the standard care of patients with overweight/obesity and pre-diabetes.

Participants will be recruited among the outpatient population who routinely refer to the Lennar Foundation Comprehensive Diabetes Center Outpatient Clinics, Division of Endocrinology, Diabetes and Metabolism University of Miami, for standard care and management of diabetes, obesity, overweight, hypertension, dyslipidemia.

Once patient eligibility and written consent are obtained, participant is then scheduled for the clinic visit through the University of Miami UChart (Epic) electronic system. The visits will be coordinated by the research coordinator. At each visit each patient will undergo:

* Full physical examination, body weight, height, waist and hip circumference, blood pressure (standard of care)

* Fasting blood glucose and haemoglobinA1c (HbA1c), lipid panel, comprehensive metabolic panel, fasting insulin, C-peptide and pro-insulin (all procedures are standard of care)

* Ultrasound assesment of epicardial fat, performed on site

* HealthSnap assessment performed on site (if randomized to the group receiving additional Healthnap)

* Standard of care dietary counselling performed on site by a registered dietitian (if randomized to the control group)

Study patients and controls will be contacted by the dietitian and/or HealthSnap supervisor once a week via telephone, or email (Uchart) or via online session (collaborate Ultra) to monitor their compliance and adherence to the exercise and dietary program.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2018-06-01
• Study First Submitted: 2018-09-21
• Study First Submitted QC: 2018-09-21
• Study First Posted: 2018-09-25
• Status Verified: 2020-09
• Primary Completion: 2020-09-10
• Study Completion: 2020-09-10
• Last Update Submitted: 2020-09-11
• Last Update Posted: 2020-09-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Body mass index (BMI) ≥ 27 kg/m2
• HbA1c 5.7-6.5% within 3 months the initial visit and/or
• Fasting blood glucose (FBG) 100-125 mg/dl within 3 months the initial visit and/or
• Family history for diabetes or CAD or dyslipidemia

Read More

Exclusion Criteria

• • Type 1 diabetes

  • Pregnancy
  • Mental illness preventing correct use of HealthSnap
  • Physical inability to follow HealthSnap recommendations
  • Active infective and neoplastic diseases
  • No current diabetes medications with the exception of Metformin
  • Chemotherapy

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Healthsnap	HealthSnap	50 patients will receive HealthSnap assessment in addition to their current treatment regardless of their participation into the study
Diet	dietary counseling	50 patients will receive standard of care dietary counselling in addition to their current treatment regardless of their participation into the study

Primary Outcome Measures

Name	Time	Method
Epicardial fat thickness (EAT)	3 months	Change in ultrasound measured EAT

Secondary Outcome Measures

Name	Time	Method
Body Mass Index (BMI)	3 months	Change in BMI
Hemoglobin A1c (HbA1c) percentage (%)	3 months	Change in the HbA1c %

Trial Locations

Locations (1)

University of Miami; 🇺🇸 Miami, Florida, United States